RT Journal Article
SR Electronic
T1 Protocol for Systematic Review and Meta-Analysis of Prehospital Large Vessel Occlusion Screening Scales
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.19.24312257
DO 10.1101/2024.08.19.24312257
A1 Suzuki, Hidetaka
A1 Okada, Yohei
A1 Hiroshi, Yamagami
A1 Hayakawa, Mikito
A1 Takeshi, Yoshimoto
A1 Kobata, Hitoshi
YR 2024
UL http://medrxiv.org/content/early/2024/08/20/2024.08.19.24312257.abstract
AB Background Large Vessel Occlusion (LVO) is a serious condition that causes approximately 24-46% of acute ischemic strokes (AIS). LVO strokes tend to have higher mortality rates and result in more severe longterm disabilities compared to non LVO ischemic strokes. Early intervention with endovascular therapy (EVT) is recommended; however, EVT is limited to tertiary care hospitals with specialized facilities. Therefore, identifying patients with a high probability of LVO in prehospital settings and ensuring their rapid transfer to appropriate hospitals is crucial. While LVO diagnosis typically requires advanced imaging like MRI or CT scans, various scoring systems based on neurological symptoms have been developed for prehospital use. Although previous systematic reviews have addressed some of these scales, recent studies have introduced new scales and additional data on their accuracy. This systematic review and meta-analysis aim to summarize the current evidence on the diagnostic accuracy of these prehospital LVO screening scales.Methods This systematic review and meta-analysis will be conducted in accordance with the PRISMA-DTA Statement and the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. We will include observational studies and randomized controlled trials that assess the utility of LVO scales in suspected stroke patients in prehospital settings. Eligible studies must provide sufficient data to calculate sensitivity and specificity, and those lacking such data or being case reports will be excluded. The literature search will cover CENTRAL, MEDLINE, and Ichushi databases, including studies in English and Japanese. Bias will be assessed using QUADAS-2, and meta-analysis will be conducted using a random effects model, with subgroup and sensitivity analyses to explore heterogeneity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We will search the following databases CENTRAL, MEDLINE, and Ichushi.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.